Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 14, 2022; 28(38): 5573-5588
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5573
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5573
Figure 6 Hypoxia-inducible factor transcriptionally upregulates interleukin-1 receptor antagonist expression.
A: Luciferase assay for the wild-type promoter (-2113/+143) of interleukin-1 receptor antagonist (Il1ra) in AML12 cells; B: Luciferase assay for the wild-type promoter of Il1ra in AML12 cells upon hypoxia; C: Luciferase assay for wild-type and truncated promoters of Il1ra in AML12 cells upon hypoxia; D: Luciferase assay for wild-type (-2113/+143) and HRE-mutated promoters of Il1ra upon hypoxia; E: Chromatin immunoprecipitation assay for hypoxia-inducible factor (HIF)-1α binding to HRE sites upon hypoxia; F and G: Quantitative polymerase chain reaction analysis for the recruitment of HIF-1α to the endogenous Il1ra promoter in AML12 cells upon hypoxia. Indicated P-values were calculated using two-tailed unpaired Student’s t-tests. Data are presented as the mean ± SEM. Data are representative of independent experiments. nsP > 0.05, aP < 0.01, bP < 0.001. Hypo: Hypoxia; IS: Ischemia; HIF: Hypoxia-inducible factor; IL-1ra: Interleukin-1 receptor antagonist; IgG: Immunoglobulin G.
- Citation: Wang ZY, Liu Y, Li SP, Li JJ, Zhang Z, Xiao XC, Ou Y, Wang H, Cai JZ, Yang S. Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury. World J Gastroenterol 2022; 28(38): 5573-5588
- URL: https://www.wjgnet.com/1007-9327/full/v28/i38/5573.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i38.5573